H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 8.6% of adults in Stamford have diagnosed diabetes — 3.4 points below the U.S. 12% figure. Census population 135,470. Connecticut Medicare wound biologics: National Government Services (NGS) (JK). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Stamford clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Stamford storefront.
Skin Substitute Therapy Products in Stamford, CT for clinics & physicians. Skin substitute therapy for com… Compliance support & pricing — contact Hawk Medical.
CDC PLACES (2023, crude) estimates 8.6% of adults in Stamford have diagnosed diabetes — 3.4 points below the U.S. 12% figure. Obesity 25.5%; arthritis 19.3%. Those three PLACES crude rates (plus Census 135,470) are the local facts on this page. Everything else is the national skin substitute therapy catalog and JK paperwork.
National Skin Substitute Therapy Products notes (how the product actually works)12.3% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. A city under 250k with 135,470 residents will still mix those payers. CDC PLACES (2023, crude) estimates 8.6% of adults in Stamford have diagnosed diabetes — 3.4 points below the U.S. 12% figure. Build two utilization policies if you do both cash PRP and Medicare CTPs.
The 96.5% hematogel figure on our wound materials is product-level clinical experience, not a Stamford trial. Local outcomes stay with the treating physician. CDC PLACES (2023, crude) estimates 8.6% of adults in Stamford have diagnosed diabetes — 3.4 points below the U.S. 12% figure. Use that rate for inventory math, not for ads.
CDC PLACES (2023, crude prevalence) estimates 8.6% of adults — 3.4 points below the U.S. 12% figure. Obesity is 25.5%; arthritis is 19.3%. That is place-level BRFSS modeling, not a clinic census and not a Stamford trial.
Point-of-care spin, kit handling, and documentation basics. Injection technique, privileging, and ultrasound guidance remain the clinic’s clinical education path in Connecticut.
No. Hawk Medical does not distribute products as “stem cell therapy.” HCT/P 361 allografts are regulated under 21 CFR 1271 for homologous use and minimal manipulation. PRP is autologous. Marketing that blurs those lanes is a compliance problem in every state, including Connecticut.
No. PRP (autologous) and cellular/tissue products (allograft/skin substitutes) sit on different coding and coverage paths. National Government Services (NGS) LCDs for CTPs do not automatically cover PRP injections. Build separate protocols and fee tickets.
Bring specialty, monthly wound volume, and whether you bill JK FFS, Advantage, workers’ comp, or cash-pay. We already have PLACES 8.6% diabetes and 19.3% arthritis for Stamford — tell us how that matches your panel. Book 15 minutes with Joe or use the contact form.
Contact us to learn how Hawk Medical supports practices in Stamford, CT.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Stamford is JK geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Stamford — 3.4 points below the U.S. 12% figure. Planning input, not an outcomes claim.
Connecticut Part B wound biologics follow this contractor (siblings: MA, ME, NH, NY, RI, VT). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Stamford. Useful for joint-program math; still needs a diagnosis and privileging.
No Stamford storefront. Joe Bradley is an active practice owner. skin substitute therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.